Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Astellas presents promising in vitro and in vivo results for a novel antifungal agent

Sep. 14, 2012

Galapagos presents promising in vivo results for GLPG-0492

Sep. 13, 2012

Results reported from phase II studies of BI-671800 in adult asthma

Sep. 13, 2012

Cubist Pharmaceuticals presents novel, broad-spectrum cephalosporin

Sep. 13, 2012

Frontier Biotechnologies presents early clinical data for albuvirtide

Sep. 13, 2012

Researchers from Peregrine present topline results from a phase II study in NSCLC

Sep. 12, 2012

Radiolabeled TSPO shows potential as a new imaging biomarker of NAFLD

Sep. 12, 2012

Sanofi presents novel PI3K-beta inhibitor with activity in PTEN-deficient tumors

Sep. 12, 2012

SQ-609: a dipiperidine for tuberculosis

Sep. 12, 2012

AEterna Zentaris presents promising in vivo data for AEZS-136

Sep. 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.